总生存预后模型对头颈癌多学科会诊决策过程的影响
研究通过定量与定性方法评估个体化总生存预后模型OncologIQ在多学科会诊中的使用价值及对决策的影响。医护人员在47.5%的测量中感受到该模型带来的附加价值;对老年患者、WHO体能评分≥2或高肿瘤分期患者,模型对决策过程有显著影响。结论认为OncologIQ有助于以患者为中心的决策,在复杂患者中价值最高。
要点
- OncologIQ个体化总生存预后模型在多学科会诊中使用时,医护人员在47.5%的测量中感受到附加价值。
- 对老年患者、WHO体能评分≥2或高肿瘤分期患者,OncologIQ对决策过程有显著影响。
- OncologIQ有助于以患者为中心的决策,在复杂患者中价值最高。
核心结论
- OncologIQ预后模型能够支持多学科会诊中以患者为中心的决策,且在复杂患者中价值最高。
研究设计与样本
- 采用定量与定性研究方法,评估OncologIQ在多学科会诊决策过程中的使用价值与影响。
主要发现
- 医护人员在使用OncologIQ提供的生存预后估计时,在47.5%的测量中感受到附加价值。
- 当OncologIQ用于老年患者、WHO体能评分≥2或高肿瘤分期患者时,对决策过程有显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multidisciplinary decision-making in head and neck cancer care is complex and requires a tradeoff between prolonging survival and optimizing quality of life. To support prognostication and decision-making in head and neck cancer care, an individualized prognostic model for overall survival (OncologIQ) is available. METHODS: By quantitative and qualitative research we have studied user value of OncologIQ and its impact on the decision-making process in a multidisciplinary consultation meeting. RESULTS: Healthcare professionals experienced added value upon using prognostic estimates of survival from OncologIQ in half (47.5%) of the measurements. Significant impact on the decision making process was seen when OncologIQ was used for older patients, patients having a WHO performance score ≥ 2, or high tumor stage. CONCLUSIONS: The prognostic model OncologIQ enables patient-centered decision-making in a multidisciplinary consultation meeting and was mostly valued in complex patients.
引用
- Dorr MC, Hoesseini A, Sewnaik A, et al. Impact of a prognostic model for overall survival on the decision-making process in a head and neck cancer multidisciplinary consultation meeting. Head Neck. 2022. PMID: 35906922. doi:10.1002/hed.27163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。